NEOGEN CHEMICALS LIMITED Intrinsic Value
NEOGEN · Chemicals · Current price ₹2,127.8
Is NEOGEN CHEMICALS LIMITED undervalued?
DocStoX estimates the fair value of NEOGEN CHEMICALS LIMITED at ₹656 per share, versus the current market price of ₹2,128. That puts the stock about -69.2% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹270), Relative P/E (₹568), Graham floor (₹275), Analyst target (₹2,198). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹270 (bear) to ₹656 (base) to ₹2,198 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹2,128 versus an intrinsic value of ₹656, NEOGEN CHEMICALS LIMITED currently offers -69.2% of negative margin (i.e. a premium).
More on NEOGEN CHEMICALS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.